目的探讨重组人甲基CpG结合蛋白2(MeCP2)处理的视网膜色素上皮(RPE)细胞中mRNA和N6-甲基腺嘌呤(m6A)改变及其机制。
方法将传代ARPE-19细胞贴壁培养后分为正常对照组和MeCP2组,正常对照组细胞采用正常培养液培养,MeCP2组细胞于含终质量浓度20 ng/ml重组人MeCP2蛋白培养液中,连续培养72 h。提取细胞内总RNA进行转录组测序(RNA-seq)和甲基化免疫共沉淀测序(MeRIP-seq)分析。采用edgeR软件包根据 P<0.05筛选差异表达基因(DEGs)和差异甲基化基因(DMGs)。采用基因本体论(GO)富集分析对差异基因进行生物学功能描述,采用京都基因和基因组百科全书(KEGG)进行通路富集分析。筛选出DEGs与DMGs交集的基因,采用实时荧光定量PCR技术检测各组差异基因mRNA表达水平。
结果共筛选出DEGs 100个,DMGs 7 441个,富集分析发现DEGs与细胞外基质(ECM)-受体相互作用、细胞分裂、细胞周期和磷脂酰肌醇3激酶/蛋白激酶B(PI3K/AKT)信号通路等相关,DMGs与微管细胞骨架、血管生成、表皮生长因子受体(ErbB)信号通路、晚期糖基化终末产物(AGEs)-糖基化终末产物受体(RAGE)信号通路、哺乳动物雷帕霉素靶蛋白(mTOR)信号通路、Notch信号通路和转化生长因子β(TGF-β)信号通路等相关。DEGs中24个基因表达增加,76个基因表达减少;DMGs中5个基因含有高甲基化峰,7 439个基因含有低甲基化峰,注释峰后,正常对照组有7 626个基因发生m6A甲基化,MeCP2组有8 006个基因发生m6A甲基化,2个组间有7 360个交集基因。正常对照组和MeCP2组的m6A甲基化富集于转录本的CDS、内含子和3'-非翻译区(3'UTR)区域,其甲基化比例分别为23.62%/22.27%、48.53%/48.35%和23.66%/25.28%。联合分析发现2个上皮-间充质转化(EMT)相关基因 CSPG5和 RBP1的mRNA和m6A水平均降低。荧光定量PCR结果显示,MeCP2组 GSPG5、 RBP1、 ZNF484 mRNA相对表达量均明显低于正常对照组,差异均有统计学意义( t=7.885、7.613、7.345,均 P<0.01)。
结论RPE细胞中MeCP2对EMT的调控机制与m6A甲基化修饰相关。 CSPG5和 RBP1基因可能是m6A甲基化的靶基因,参与MeCP2调控的EMT过程。
ObjectiveTo investigate mRNA and N6-methyladenosine (m6A) changes in retinal pigment epithelium (RPE) cells treated with recombinant human methyl-CpG binding protein 2 (MeCP2) and the mechanisms.
MethodsThe passaged ARPE-19 cells were divided into normal control and MeCP2 groups after adhesion culture.Cells in the normal control group were continuously cultured in normal culture medium, and the cells in the MeCP2 group were cultured in culture medium containing a final concentration of 20 ng/ml of recombinant human MeCP2 protein for 72 hours.Transcriptomic sequencing (RNA-seq) and methylated RNA immunoprecipitation sequencing (MeRIP-seq) were used to extract and analyze total RNA.Differentially methylated genes (DMGs) and differentially expressed genes (DEGs) were screened using the edgeR software package based on P<0.05.The biological function of differential genes was determined by gene ontology (GO) enrichment analysis, and the pathway enrichment analysis was performed by Kyoto Encyclopedia of Genes and Genomes (KEGG).Intersection of genes between DEGs and DMGs were screened, and real-time fluorescence quantitative PCR was used to determine the mRNA expression levels of differential genes.
ResultsA total of 100 DEGs and 7 441 DMGs genes were screened.According to enrichment analysis, the DEGs were enriched to extracellular matrix (ECM)-receptor interaction, cell division, phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT) signaling pathway and so on.The DMGs were associated with microtubule cytoskeleton, angiogenesis, epidermal growth factor receptor (ErbB) signaling pathway, advanced glycation end-products (AGEs) -glycation end-products receptor (RAGE) signaling pathway, mammalian target of rapamycin (mTOR) signaling pathway, Notch signaling pathway and transforming growth factors-β (TGF-β) signaling pathway and so on.There were 24 up-regulated and 76 down-regulated DEGs.Five DMGs had hypermethylation peaks, and 7 439 DMGs had hypomethylation peaks.After annotation of peaks, 7 626 genes in the normal control group and 8 006 genes in the MeCP2 group had m6A methylation, with 7 360 intersecting genes between the two groups.The m6A methylation in the normal control group and MeCP2 group was concentrated in the CDS, intron and 3'-untranslated region (3'UTR) regions of the transcript, with the methylation ratio of 23.62%/22.27%, 48.53%/48.35% and 23.66%/25.28%, respectively.Joint analysis showed that CSPG5 and RBP1 genes related to the epithelial-mesenchymal transition (EMT) had lower amount of mRNA and m6A.Fluorescence quantitative PCR results showed that the relative mRNA expression levels of GSPG5, RBP1 and ZNF484 in MeCP2 group were significantly lower than those in normal control group ( t=7.885, 7.613, 7.345; all at P<0.01).
ConclusionsThe regulatory mechanism of MeCP2 on EMT in RPE cells is related to m6A methylation modification. CSPG5 and RBP1 genes may be the target genes of m6A methylation and participate in the EMT regulated by MeCP2.
张咏雅,李晓华,赵雪茹,等. MeCP2诱导的视网膜色素上皮细胞转录组和m6A的改变[J]. 中华实验眼科杂志,2024,42(05):408-416.
DOI:10.3760/cma.j.cn115989-20230920-00105版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
张咏雅:起草文章、实施研究、采集数据、统计分析、分析/解释数据;李晓华:设计实验、获取研究经费、指导实验、文章审阅、修改及定稿;赵雪茹、李雪:实施研究、采集数据、统计分析

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。